Arachidonate 5-lipoxygenase (ALOX5) plays a role in the synthesis of leukotrienes from arachidonic acid, and inhibition of the ALOX5 pathway markedly reduces the number of Kupffer cells in culture and attenuates inflammation and fibrosis in experimental liver disease (Titos et al., 2003). Here, ALOX5 is linked to liver disorder.